NCT01639456 2017-12-02CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete RemissionMasonic Cancer Center, University of MinnesotaPhase 2 Withdrawn